UK Cardiovascular Market Analysis


  • Type: Therapeutics Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2502

  • Format: PPT, PDF

UK Cardiovascular Therapeutics Market: Segmented by Disease type, Drug class, Drug type- Growth, Trends, and Forecasts (2019 – 2028)

SKU: 2502 Categories: ,

Report Overview

UK Cardiovascular therapeutics market size stood at around USD XX.X billion in 2019 and will be growing, exhibiting a CAGR of 6.4% during the forecast period from 2019 to 2028.

Cardiovascular therapeutic drugs refer to the prescribed medicines and drugs for the diseases which are related to the functioning and treatment of heart and blood vessels. While cardiovascular diseases remain to be the leading cause of dead, the major reason causing cardiovascular problems include heart failure, blood clots, coronary artery disease, high cholesterol, and others.

UK has the highest number of CVD, Congenital heart disease (CHD), stroke, heart failure, atrial fibrillation and other heart related disease that further contributing to the growth of the market. According to one of the reports published by the British Heart Foundation in 2017, more than one-fourth of the fatalities in UK are due to CVD, which is responsible for around 1.6 million fatalities each year. The above data reflects the mortalities recorded in England, Wales, Scotland, and Northern Ireland. A total of 56,493 mortalities were recorded in England followed by 7,182 in Scotland. Similarly, Wales and Northern Ireland reported 4,082 and 1,825 deaths, respectively. These numbers of mortalities and incidence of heart related diseases increase the demand for cardiovascular devices, drugs and surgeries that further propels the market growth.

Market Driving and Restraining Factors

Driving Factors

The market is driven by a host of factors which includes rise in aging population, rise in per capita spending on healthcare and epidemic of general medical issues like obesity and diabetes. With cardiovascular disorders being the most common cause for morbidity and mortality, the market has a tremendous value and continue to do so in the coming years.

Restraining Factors

There are a few restraints for the market growth which includes rising costs for drug development and lowering of target population. And, despite of high prevalence, drug develop pipelines for cardiovascular disorders has been stagnant for a variety of reasons.

1. UK Cardiovascular Therapeutics Market Overview………………………………
A. Market Size
2. Market Driving and Restraining Factors………………………………….…….
A. Driving Factors
a. Rise in aging population
b. Rise in per capita spending on healthcare
c. Cardiovascular disease being major cause of death
B. Restraining Factors
a. Rising costs for drug development
3. Major Cardiovascular diseases………………………………………………………………
A. Hypertension
B. Hyperlipidaemia
C. Coronary Artery Disease
D. Arrhythmia and Others
4. Cardiovascular Therapeutics Market Segmentation……………………………..
A. By Type of disease
I. Thrombosis
II. Arteriosclerosis
III. Myocardial infarction
IV. Cardiac arrhythmias
V. Peripheral artery disease
B. By Type of Medication
I. Prescription Only
III. Prescription and OTC
C. By Drug Class
I. Combination drug class
II. Monotherapies.
D. By Drug Type
I. Antihypertensive
II. Antihyperlipidemic
III. Anticoagulants
IV. Antiarrhythmics
5. Cardiovascular Major Products Market Share………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Bristol-Myers Squibb Company overview, Product & Services, Strategies & Financials
B. Novartis Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Dermatology drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Type of disease:

UK cardiovascular therapeutics market can be segmented based on type of disease. These various cardiovascular diseases are:

  • Thrombosis
  • Atrial fibrillation
  • Myocardial infarction
  • Cardiac arrhythmias
  • Coronary artery disease
  • Others

Among above diseases the most prevailing disease is Atrial Fibrillation followed by Coronary artery disease.

By Type of Medication


Prescription only segment leads with 47% in cardiovascular segmentation by medication type.

By Drug Class:

Based on the drug class the market is further categorized into segmentation drug classes and monotherapies.

By Drug Type:

On lines with global scenario, UK cardiovascular therapeutics market can also be segmented based on drug type as:

  • Antithrombotic drugs
  • Antidyslipidemic drugs
  • Antihypertensive drugs
  • Anti-stroke drugs

Major Players

The companies which are contributing to the growth of UK cardiovascular market include BMS, Novartis, J&J, Bayer AG, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, General Electric Co., Medtronic PLC, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements